$703 Million is the total value of Hikari Power Ltd's 69 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 575.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | Buy | ALLERGAN PLCsponsored adr | $17,059,000 | +36.5% | 71,400 | +20.0% | 2.43% | +36.7% |
| NVO | Buy | NOVO-NORDISK A Ssponsored adr | $14,528,000 | -1.5% | 423,800 | +3.1% | 2.07% | -1.4% |
| GILD | Buy | GILEAD SCIENCES INC | $3,511,000 | +25.7% | 51,700 | +32.6% | 0.50% | +25.9% |
| WAB | New | WABTEC CORPORATION | $1,849,000 | – | 23,700 | +100.0% | 0.26% | – |
| BUD | Buy | Anheuser-Busch InBevsponsored adr | $1,109,000 | +75.2% | 10,100 | +68.3% | 0.16% | +75.6% |
| DBVT | New | DBV TECHNOLOGIES SAsponsored adr | $1,026,000 | – | 29,119 | +100.0% | 0.15% | – |
| FOX | New | TWENTY-FIRST CENTURY FOX INC | $925,000 | – | 29,100 | +100.0% | 0.13% | – |
| AMAG | New | AMAG PHARMACEUTICALS INC | $902,000 | – | 40,000 | +100.0% | 0.13% | – |
| OPK | New | OPKO HEALTH INC | $715,000 | – | 89,405 | +100.0% | 0.10% | – |
| TGTX | New | TG THERAPEUTICS INC | $699,000 | – | 60,000 | +100.0% | 0.10% | – |
| SGYPQ | New | SYNERGY PHARMACEUTICALS INC | $699,000 | – | 150,000 | +100.0% | 0.10% | – |
| BIVV | New | BIOVERATIV INC | $599,000 | – | 11,000 | +100.0% | 0.08% | – |
| BDSI | New | BIODELIVERY SCIENCES INTERNATIONAL INC | $503,000 | – | 264,610 | +100.0% | 0.07% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $440,000 | – | 60,000 | +100.0% | 0.06% | – |
| SELB | New | SELECTA BIOSCIENCES INC | $349,000 | – | 24,369 | +100.0% | 0.05% | – |
| OCRX | New | OCERA THERAPEUTICS INC | $328,000 | – | 250,000 | +100.0% | 0.05% | – |
| SYNT | New | SYNTEL INC | $332,000 | – | 19,700 | +100.0% | 0.05% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORPORATION | $298,000 | – | 50,000 | +100.0% | 0.04% | – |
| ANIP | New | ANI PHARMACEUTICALS INC | $248,000 | – | 5,000 | +100.0% | 0.04% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $210,000 | – | 10,000 | +100.0% | 0.03% | – |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $200,000 | – | 11,743 | +100.0% | 0.03% | – |
| ALDX | New | ALDEYRA THERAPEUTICS INC | $188,000 | – | 37,662 | +100.0% | 0.03% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC | $181,000 | – | 50,000 | +100.0% | 0.03% | – |
| ABEO | New | ABEONA Therapeutics | $150,000 | – | 30,000 | +100.0% | 0.02% | – |
| EIGR | New | EIGER BIOPHARMACEUTICALS INC | $118,000 | – | 10,320 | +100.0% | 0.02% | – |
| BTX | New | BIOTIME INC | $122,000 | – | 35,274 | +100.0% | 0.02% | – |
| PRQR | New | PROQR THERAPEUTICS NV | $121,000 | – | 24,144 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Yasumitsu Shigeta #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-04-26
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CARDINAL HEALTH | 39 | Q3 2023 | 40.7% |
| WELLS FARGO & CO NEW | 39 | Q3 2023 | 17.8% |
| JOHNSON & JOHNSON | 39 | Q3 2023 | 24.8% |
| VISA INC CLASS A | 39 | Q3 2023 | 4.1% |
| NOVO-NORDISK A S | 39 | Q3 2023 | 4.2% |
| EXXON MOBIL CORPORATION | 39 | Q3 2023 | 3.9% |
| NESTLE SA | 39 | Q3 2023 | 3.6% |
| COCA COLA CO | 39 | Q3 2023 | 6.4% |
| INTUITIVE SURGICAL INC | 39 | Q3 2023 | 2.2% |
| BECTON DICKINSON & CO | 39 | Q3 2023 | 2.8% |
View Hikari Power Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-08 |
| 13F-HR | 2024-01-31 |
| 13F-HR | 2023-10-26 |
| 13F-HR | 2023-07-26 |
| 13F-HR | 2023-04-26 |
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-11-01 |
| 13F-HR/A | 2022-07-22 |
| 13F-HR | 2022-07-06 |
| 13F-HR | 2022-04-13 |
View Hikari Power Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.